Insulin-Like Growth Factor Binding Protein-3 Has Dual Effects on Gastrointestinal Stromal Tumor Cell Viability and Sensitivity to the Anti-Tumor Effects of Imatinib Mesylate in Vitro

Molecular Cancer - United Kingdom
doi 10.1186/1476-4598-8-99
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Histone H2AX Is a Mediator of Gastrointestinal Stromal Tumor Cell Apoptosis Following Treatment With Imatinib Mesylate

Cancer Research
Cancer ResearchOncology
2007English

Establishment of Imatinib-Resistant Gastrointestinal Stromal Tumor Cell Subline and Investigation of Its Sensitivity to the Chemomotherapeutic Agents

Kazan medical journal
2017English

Effects of Hibiscus Sabdariffa Linn. On Insulin-Like Growth Factor Binding Protein 3 (IGFBP-3) to Prevent Overtraining Syndrome

Medical Journal of Indonesia
Medicine
2015English

Mitogenic Properties of Insulin-Like Growth Factors I and II, Insulin-Like Growth Factor Binding Protein-3 and Epidermal Growth Factor on Human Breast Stromal Cells in Primary Culture

Breast Cancer Research and Treatment
Cancer ResearchOncology
2004English

A Case of Postoperative Recurrence of Peritoneal Dissemination Due to Gastrointestinal Stromal Tumor of the Ileum Responding to Imatinib Mesylate

Japanese Journal of Gastroenterological Surgery
SurgeryGastroenterology
2005English

Variation in Plasma Insulin-Like Growth Factor-1 and Insulin-Like Growth Factor Binding Protein-3: Genetic Factors

Cancer Epidemiology Biomarkers and Prevention
MedicineEpidemiologyOncology
2005English

Biological Effects of Prostate Specific Antigen as an Insulin-Like Growth Factor Binding Protein-3 Protease

Journal of Endocrinology
EndocrinologyMetabolismDiabetes
1994English

Insulin-Like Growth Factor-Binding Protein

2020English

RACK1 Overexpression Is Linked to Acquired Imatinib Resistance in Gastrointestinal Stromal Tumor

Oncotarget
Oncology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy